Tazarotene 0.1% Cream as Monotherapy for Early-Stage Cutaneous T-Cell Lymphoma. [electronic resource]
Producer: 20170626Description: 244-8 p. digitalISSN:- 1615-7109
- Administration, Cutaneous
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Disease-Free Survival
- Female
- Humans
- Lymphoma, T-Cell, Cutaneous -- drug therapy
- Male
- Middle Aged
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Nicotinic Acids -- administration & dosage
- Prospective Studies
- Skin Neoplasms -- drug therapy
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.